AIM Financials
Aim Immunotech Inc - Financial statements & key metrics
Stock Price
$0.24
Market Cap
$3.45M
EPS
$-4.31
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$88000.00
Gross Profit
$-250000.00
Operating Income
$-10.53M
Net Income
$-13.96M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$5.78M
Total Liabilities
$15.56M
Shareholders Equity
$-9.78M
Cash & Equivalents
$931000.00
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-10.96M
CapEx
$378000
Free Cash Flow
$-11.34M
Profitability Metrics
Gross Margin
-45.5%
Operating Margin
-140.6%
ROE
-31.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AIM revenue?
AIM's most recent quarterly revenue was $88000.00. Annual revenue can be calculated by summing the four most recent quarters.
Is AIM profitable?
AIM reported a loss of $13.96M in the most recent quarter.
What is AIM market cap?
AIM has a market capitalization of $3.45M, making it a small-cap stock.
Does AIM have debt?
View AIM's balance sheet for debt information.
What is AIM cash flow?
AIM's most recent quarterly free cash flow was $-11.34M.